Danae Dirocco is a Psychiatry physician. OpenAlex indexes 10 publications with 717 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2500 Metrohealth Dr
Cleveland, OH 441091900
Telephone
216-778-7800Provider last certified this registry record 25 Sept 2020.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AbbVie Inc.Program year20235 payments
- Janssen Pharmaceuticals, IncProgram year20233 payments
- Alkermes, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Atypical Antipsychotic32.6%Quetiapine Fumarate25%Aripiprazole21%Clozapine18%Olanzapine15%Risperidone14%Invega Sustenna7%Part D<11 patientsSSRI24.3%Sertraline Hcl33%Trazodone Hcl28%Escitalopram Oxalate24%Fluvoxamine Maleate15%Part D<11 patients+ 7 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Public sector low threshold office-based buprenorphine treatment: outcomes at year 7
Addiction Science & Clinical Practice
2017 - Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City
Drug and Alcohol Dependence
2016 - A better approach to opioid prescribing in primary care.
PubMed
2014 - Variation in Use of Buprenorphine and Methadone Treatment by Racial, Ethnic, and Income Characteristics of Residential Social Areas in New York City
The Journal of Behavioral Health Services & Research
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”